Identification and biological significance of G protein-coupled receptor associated sorting proteins (GASPs)

https://doi.org/10.1016/j.pharmthera.2010.03.004Get rights and content

Abstract

G protein-coupled receptors (GPCRs) represent one of the most abundant protein families encoded by the human genome. They are involved in the modulation of numerous physiological functions and represent major drug targets. Their activity is tightly controlled by a vast array of interacting partners that modulate their membrane targeting, intracellular trafficking and signalling properties. Among them, several proteins from the same family, G protein-coupled receptor associated sorting proteins (GASP), have been shown to display a broad spectrum of interactions with GPCRs. In addition to their postulated role in the modulation of the post-endocytic sorting of these receptors, recent data indicate that several GASPs may modulate the transcriptional activity of the cell through their interaction with transcription factors. However, no clear molecular function has been assigned yet to this protein family. In this review, we describe the discovery of GASPs, their major features, interacting partners, functions and possible involvement in pathological situations including neurodegenerative diseases and cancer.

Introduction

G protein-coupled receptors (GPCRs) represent one of the most abundant protein families encoded by the human genome. By the most recent estimations there are a total of 799 sequence verified human GPCRs, of which 369 respond to endogenous ligands (see Lagerstrom & Schioth, 2008). These ligands display an extraordinary diversity, including amino acids, Ca2+ ions, peptides, lipid-like substances and large glycoprotein hormones. In animals, all physiological functions are modulated by complex equilibriums between different subsets of GPCRs. From a pharmaceutical point of view, these receptors are targeted by around 40% of all drugs available on the market (see Jacoby et al., 2006, Eglen et al., 2007). Noticeably, these compounds act through less than 50 different GPCRs leaving more than 300 receptors as potential targets for the development of therapeutic agents (see Lagerstrom & Schioth, 2008).

The activity of GPCRs is tightly regulated. Particularly, they interact with a vast repertoire of GPCR interacting proteins (GIPs) that display important functions, including the targeting of receptors to specific subcellular compartments, their trafficking to and from the plasma membrane and the fine-tuning of their signalling properties (see Bockaert et al., 2004). Consequently, if we want to discover and optimize new therapeutic agents targeting GPCRs we must appreciate the functioning of these novel interacting partners.

With the exception of arrestins, for which the interaction with numerous GPCRs has been largely demonstrated (see Pierce et al., 2002), most GIPs modulate the function of only one or a small subset of GPCRs. Some are transmembrane proteins while other are cyto-soluble and mainly interact with the C-terminal tail (C-tail) of receptors. In this review, we will describe the discovery and potential functions of a novel family of proteins, the so-called GPCR associated sorting proteins (GASPs). Like arrestins, they display a broad spectrum of interaction with GPCRs and may therefore represent an important family of proteins regulating GPCR physiology.

Section snippets

Discovery of GASPs

The first member of the GASP family was originally identified by a Japanese group using the PAS domain of rat Period1 as bait in a two-hybrid screen of a cDNA library from rat suprachiasmatic nucleus (Matsuki et al., 2001). This protein was therefore called PIPS (Period1 interacting protein of the suprachiasmatic nucleus). It was further shown to display a strong sequence homology with a human protein, KIAA0443, identified at the Kazusa DNA Research Institute in a project aiming to identify

GASPs are members of a single gene family

Despite the lack of homogeneity in the official nomenclature, as discussed above, there is a variety of evidences showing that GASP-1 to -10 belong to the same protein family. First of all, GASP-1 to -10 display significant sequence similarities. As shown in Fig. 1, they share a conserved C-terminal domain of 250 amino acids. This region displays 20 to 77% sequence identity in pairwise comparisons between GASP-1 and other GASPs. In addition, we have identified a highly conserved and repeated

Functions of GASPs

Although no clear molecular function has been assigned to this protein family, several studies point to their implications in at least two different cellular activities.

GASPs and diseases

There are few reports of GASPs in pathological situations. Most of them are based on transcriptomic studies showing alteration of mRNA levels of different GASPs. Except for two studies, one showing that GASP-3 mRNA level is decreased in the brain of Alzheimer's disease patients (Heese et al., 2004), and a second one that places GASP-4 in a list of 892 highly dysregulated priority genes in the brain of Parkinson's disease patients (Moran & Graeber, 2008), all other reports describe the possible

Conclusion

Despite their very different sizes, ranging from 249 to 1395 amino acids, GASPs share many common features both in terms of sequence similarities, gene organization and functions. The GASP subfamily 1 is clearly involved in the modulation of GPCR activity and could modulate transcription, while the GASP subfamily 2 is mostly involved in the modulation of transcription, particularly through interactions with known transcription factors. Considering these two functions, it is tempting to

Acknowledgments

This study was supported by The Centre National de la Recherche Scientifique and the Université de Strasbourg (AA and FS), the Association pour la Recherche sur le Cancer (FS, no. 3423), Fondation pour la Recherche Médicale (FS) and a fellowship from Société Française de Pharmacologie et de Thérapeutique (AA). We thank Renaud Wagner and Jeremy Garwood for critical reading of the manuscript.

References (44)

  • X. Zhou et al.

    SVH-B interacts directly with p53 and suppresses the transcriptional activity of p53

    FEBS Lett

    (2007)
  • S.E. Bartlett et al.

    Dopamine responsiveness is regulated by targeted sorting of D2 receptors

    Proc Natl Acad Sci U S A

    (2005)
  • S.A. Beausoleil et al.

    Large-scale characterization of HeLa cell nuclear phosphoproteins

    Proc Natl Acad Sci U S A

    (2004)
  • J. Boeuf et al.

    Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice

    Eur J Neurosci

    (2009)
  • S. Britsch et al.

    The transcription factor Sox10 is a key regulator of peripheral glial development

    Genes Dev

    (2001)
  • T.J. Carney et al.

    A direct role for Sox10 in specification of neural crest-derived sensory neurons

    Development

    (2006)
  • E. Cattaneo et al.

    Normal huntingtin function: an alternative approach to Huntington's disease

    Nat Rev Neurosci

    (2005)
  • N. Cermakian et al.

    Multilevel regulation of the circadian clock

    Nat Rev Mol Cell Biol

    (2000)
  • R.M. Eglen et al.

    Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening

    Assay Drug Dev Technol

    (2007)
  • S. Elworthy et al.

    Transcriptional regulation of mitfa accounts for the sox10 requirement in zebrafish melanophore development

    Development

    (2003)
  • J. Enquist et al.

    Kinins promote B2 receptor endocytosis and delay constitutive B1 receptor endocytosis

    Mol Pharmacol

    (2007)
  • J. Furuta et al.

    Silencing of peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas

    Cancer Res

    (2006)
  • Cited by (30)

    • A novel Xq22.1 deletion in a male with multiple congenital abnormalities and respiratory failure

      2016, European Journal of Medical Genetics
      Citation Excerpt :

      Within this 0.35 Mb sub-region there are five orthologous genes (ARMCX5, ARMCX5-GPRASP2, GPRASP1, GPRASP2, and BHLHB9) included in the human 1.1 Mb Xq22.1 deleted interval (Fig. 3). These five genes are paralogs and belong to GASP (G protein-coupled receptor associated sorting proteins) family (Abu-Helo and Simonin, 2010). ARMCX5 (armadillo repeat containing, X-linked 5) was recently identified and little is known about this gene.

    • XBeclin 2 functions in autophagy, degradation of G protein-coupled receptors, and metabolism

      2013, Cell
      Citation Excerpt :

      Our discovery of a role for Beclin 2 in the degradation of GASP1-regulated GPCRs represents a mechanistic advance in understanding agonist-induced GPCR degradation. GASP1, originally identified in a yeast two-hybrid screen with the C terminus of the DOR (Whistler et al., 2002), is expressed predominantly in the CNS (similar to Beclin 2) (Abu-Helo and Simonin, 2010; Simonin et al., 2004) and modulates the postendocytic sorting of a highly specific subset of GPCRs to the lysosome for degradation in a ubiquitin-independent manner (Moser et al., 2010). This targeting of GPCRs to the degradative/lysosomal pathway has been shown to regulate virally encoded GPCR signaling in vitro (Tschische et al., 2010), and manipulation of GASP1 function in vivo regulates pharmacological responses to cannabinoids (agonists of CB1R) and cocaine (an indirect agonist of the dopamine D2 receptor) (Moser et al., 2010).

    • Modulating Neuromodulation by Receptor Membrane Traffic in the Endocytic Pathway

      2012, Neuron
      Citation Excerpt :

      Overproducing a C-terminal fragment in transfected fibroblastic cells inhibited ligand-induced downregulation of coexpressed delta opioid receptors, leading to the suggestion that this protein represents a putative “G protein-coupled receptor-associated sorting protein” (GASP). A family of related GASP proteins (now called GPRASPs) was subsequently identified, which are widely expressed in mammals but not in yeast (Abu-Helo and Simonin, 2010). Supporting the potential in vivo significance of this mechanism in neurons, genetic knockout of the originally identified GASP protein (GPRASP1) in mice blocked cocaine-induced downregulation of D2 dopamine receptors in the brain (Thompson et al., 2010).

    View all citing articles on Scopus
    View full text